What is Esperion Therapeutics's EV / sales?

Esperion Therapeutics (ESPR) reported EV / sales of 1.7× in Q1 2026.

How has Esperion Therapeutics's EV / sales changed year-over-year?

Esperion Therapeutics's EV / sales increased by 37.8% year-over-year, from 1.2× to 1.7×.

What is the long-term trend for Esperion Therapeutics's EV / sales?

Over 5 years (2020 to 2025), Esperion Therapeutics's EV / sales has grown at a -18.1% compound annual growth rate (CAGR), from 5.8× to 2.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Esperion Therapeutics ESPR EV / sales

EV / sales at other companies

AmgenAMGN

6.6×+0.1×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

NewAmsterdam Pharma CompanyNAMS

142.8×+111×

Lexicon PharmaceuticalsLXRX

9.4×+2.6×

Zevra Therapeutics, Inc.ZVRA

3.7×-6.9×

Eton Pharmaceuticals, Inc.ETON

7.9×+0.4×

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Calculated from Esperion Therapeutics’s reported figures.

enterprise value/total revenue=1.7×

Based on the most recent quarter.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's EV / sales?: Esperion Therapeutics (ESPR) reported EV / sales of 1.7× in Q1 2026.
How has Esperion Therapeutics's EV / sales changed year-over-year?: Esperion Therapeutics's EV / sales increased by 37.8% year-over-year, from 1.2× to 1.7×.
What is the long-term trend for Esperion Therapeutics's EV / sales?: Over 5 years (2020 to 2025), Esperion Therapeutics's EV / sales has grown at a -18.1% compound annual growth rate (CAGR), from 5.8× to 2.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.